In adults with amyotrophic lateral sclerosis (ALS) who have slower disease progression, the stem cell therapy Neuronata-R (lenzumestrocel) — conditionally approved in South Korea for treating ALS — was found to […] The post In trial, Neuronata-R benefits ALS patients with slower progression appeared first on ALS News Today.
